精品国产一区二区桃色

Defying Stereotypes

Biochemist wins pageant crown

Miss Virginia lands title with science outreach talent
Laurel Oldach
June 1, 2019

The experiment known as elephant toothpaste may not impress many chemists. Depending on your perspective, it may not even qualify as an experiment. But performing it onstage seems to result reproducibly in victory at beauty pageants.

It worked for Alayna Westcom, crowned Miss Vermont in 2015, and again for Camille Schrier, a doctoral candidate at Virginia Commonwealth University’s school of pharmacy, who recently won the 2019 Miss Virginia competition.

For the talent portion of the competition, Schrier demonstrated and explained a simple but impressive chemical reaction that relies on iodide to catalyze a decomposition of hydrogen peroxide into water and gaseous oxygen. Onstage, with the addition of a little soap and food coloring, the product was a bubbly, photogenic crowd-pleaser that won Schrier the preliminary talent award.

Criticized for decades as frivolous or antifeminist, beauty pageants have seen declining television ratings and heightened controversy during the Me Too movement. Pageant organizations have tried to change with the times. In 2018, the Miss America Organization rebranded, ending the swimsuit competition and focusing on contestants’ professional ambitions and plans for social impact. It was that rebrand that kindled Schrier’s interest.

Camille Schrier
Miss Virginia Organization
Camille Schrier uses chemistry to re-create a substance sometimes called “elephant toothpaste” onstage in the Miss Virginia pageant in June.

A number of past pageant winners have been scientists. K谩ra McCullough, a chemist at the U.S. Nuclear Regulatory Commission, was crowned Miss USA in 2017. Nina Davuluri, Miss America 2014, entered pageants to win scholarship money to pursue an advanced degree in medicine and used her spotlight to advocate for science education. Erika Ebbel, Miss Massachusetts 2004 in the Miss America pageant, went on to earn a Ph.D. in biochemistry and start a biotech company and an advocacy nonprofit, Science from Scientists.

Schrier graduated from Virginia Tech with a major in biochemistry and systems biology. Now studying for a pharmacy degree, she that she hopes one day to work in the pharmaceutical industry on drug or vaccine development. For the next year, though, she’ll be on sabbatical from her Ph.D. program, touring the state to promote prescription drug safety and science, technology, engineering and mathematics education.

“I’m trying to be like Bill Nye,” she told Virginia Commonwealth University’s press team. “I want to get kids excited.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.